Update your knowledge about the range of glucose-lowering medicines available and their role in the treatment of type 2 diabetes.
Self-directed CPD activityToggle information
It is recommended that up to 8 hours of Group 3 CPD (or 24 CPD credits) be recorded for the purposes of self-directed pharmacist CPD.
An opportunity to reflect on your current management of patients with type 2 diabetes. Update your knowledge about the range of glucose-lowering medicines available and their role in the treatment of type 2 diabetes. How can you improve the way you support your patients with type 2 diabetes to achieve good glycaemic control and optimise long-term health outcomes?
NEW: Express version requires only 5 episodes of care
- Express version: 5 episodes of care (for up to 15 CPD credits) or
- Standard version: 10 episodes of care (for up to 24 CPD credits)
You will be given the option to submit your data once 5 episodes of care are entered, or continue to 10 episodes of care.
Pharmacy Practice Reviews use best practice standards and guidelines to help pharmacists review current practice, consider implementing changes to practice, review and reflect on these changes, and monitor progress.
All participants complete data collection for required episodes of care, receive a feedback report that includes individual results, aggregate results of all participants' practices and an expert commentary on the aggregate results. Participants are provided with a template to record their development and learning plan.
On completion of this activity you should be able to:
- Assess and recommend strategies to promote adherence to metformin and glucose-lowering medicines in people with type 2 diabetes
- Outline the role of add-on medicines to metformin in the context of the latest treatment recommendations for type 2 diabetes
- Support patients in the self-management of type 2 diabetes, including education about lifestyle modifications and ongoing monitoring
- Outline potential adverse effects of glucose-lowering medicines and recommend management options for adverse effects.
You will have access to:
- Up-to-date clinical guidance which provides evidence-based information to update your knowledge and guide your counselling encounters with patients
- Pharmacist tools that inform and support your best practice discussions with patients
- Expert commentary from pharmacist and clinical educator, Jane Ludington (St Vincent’s Hospital, University of Sydney).